APOE and Alzheimer disease: Ingenuity pathway analysis (IPA) revealed upregulated pathways in AD APOE ε4 carrier lymphocytes were more numerous and included metabolic (cholesterol biosynthesis and insulin secretion) and inflammatory pathways (Figure 5).